|Bid||85.78 x 900|
|Ask||88.28 x 900|
|Day's Range||86.10 - 87.41|
|52 Week Range||61.05 - 88.28|
|Beta (3Y Monthly)||1.09|
|PE Ratio (TTM)||29.11|
|Earnings Date||Oct 24, 2019|
|Forward Dividend & Yield||0.88 (1.03%)|
|1y Target Est||92.60|
DEERFIELD, Ill. & ROME-- -- Non-invasive metabolic monitor accurately measures patient energy expenditure Designed to help clinicians optimize nutrition therapy in support of improved patient outcomes Portable and flexible design can be used with intubated and spontaneously breathing patients Baxter International Inc. , a global leader in clinical nutrition, and COSMED srl, a worldwide leader in the ...
Baxter International Inc. , a leading global medical products company, will present at the Morgan Stanley 17th Annual Global Healthcare Conference in New York on September 9, 2019.
Zacks.com featured highlights include: Abbott Laboratories, Baxter International, First Horizon National, OUTFRONT Media and ICF International
Baxter International Inc. , a leading global medical products company, will present at the 2019 Wells Fargo Healthcare Conference in Boston on September 5, 2019. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present at 1:20 p.m.
Within MedSurg, Boston Scientific (BSX) is on track for the year-end launch of Exalt-D Single-Use Duodenoscope, which is used in ERCP procedures.
Baxter (BAX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
With the Beckley Canopy Therapeutics acquisition, Canopy Growth's (CGC) research and development endeavors would be expanding worldwide, thereby making the company a global pioneer in cannabinoid research.
Baxter’s innovative PrisMax system for managing acute kidney injury (AKI) is now FDA cleared and available in the U.S. Hamilton Health Care System, a top 10% national hospital provider in overall health care according to CareChex® medical quality ratings, and Baxter International Inc. (BAX), a global leader in acute care, today announced that Hamilton is the first health system in the U.S. to use Baxter’s new PrisMax system.
Investors target stocks that have been on a bullish run lately. Stocks seeing price strength have a high chance of carrying the momentum forward.
Pacific Biosciences (PACB) Q2 results gain from higher revenues and strong segmental performance. Contraction in gross margin remains a woe.